Gara Jalqabaatti › Dhukkuba Kroonii › California › Los Angeles
Qorannoo klinikaalii Dhukkuba Kroonii Los Angeles, CA keessatti
Qorannoo 15 Dhukkuba Kroonii f Los Angeles fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Namoota walitti qabaa jiraSadarkaa 3
- Cedars Sinai Medical Center ( Site 5080), Los Angeles
- UCLA Clinical & Translational Research Center (CTRC) ( Site 5116), Los Angeles
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 3
- Cedars Sinai Medical Center, Los Angeles
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 3
- TLC Clinical Research Inc, Los Angeles
- GastroIntestinal Bioscience, Los Angeles
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 2/3
- TLC Clinical Research Inc, Los Angeles
- GastroIntestinal Bioscience, Los Angeles
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 3
- TLC Clinical Research Inc.-Site Number: 8400030, Los Angeles
- GastroIntestinal Bioscience - Los Angeles-Site Number: 8400019, Los Angeles
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 2
- Biopharma Informatic, LLC, Los Angeles
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 2
- Biopharma Informatic, LLC, Los Angeles
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 4
- Cedars-Sinai Medical Center, Los Angeles
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 3
- Cedars Sinai Medical Center, Los Angeles
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Namoota walitti qabaa jira
- Cedars-Sinai, Los Angeles
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 3
- Keck Medicine Of USC - USC Healthcare Center 1, Los Angeles
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 4
- Cedars-Sinai, Los Angeles
Precise Infliximab Exposure and Pharmacodynamic Control
Namoota walitti qabaa jiraSadarkaa 2/3
- Children's Hospital of Los Angeles, Los Angeles
Impact of Prebiotics in Ulcerative Colitis
Namoota walitti qabaa jira
- UCLA, Los Angeles
Stem Cell Transplantation in Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 1/2
- Cedars-Sinai Medical Center, Los Angeles
Qorannoo Dhukkuba Kroonii magaalota biroo keessatti
- New York City, NYQorannoo 35
- Boston, MAQorannoo 19
- Miami, FLQorannoo 19
- Cleveland, OHQorannoo 19
- St. Louis, MOQorannoo 19
- Tyler, TXQorannoo 17
- Houston, TXQorannoo 17
- Orlando, FLQorannoo 17
- Atlanta, GAQorannoo 17
- San Antonio, TXQorannoo 15
- San Diego, CAQorannoo 15
- Colorado Springs, COQorannoo 13
Qorannoo biroo Los Angeles keessatti
- Kansara Qara'a Non-Small CellQorannoo 87
- Saree (Gosoota Hunda)Qorannoo 74
- Saree OljooQorannoo 73
- Kansarii ProstateQorannoo 61
- Kansarii ColorectalQorannoo 59
- Kansara MetastatikiiQorannoo 57
- Kansarii OvariiQorannoo 50
- Dhibee QaraQorannoo 45
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 42
- Kansarii PancreasQorannoo 35
- Kansa EndometiriyaaliiQorannoo 34
- MelanomaQorannoo 34
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.